The two facilities costing around £90m to build will be delivered over the next three years.
The first project is the new Rosalind Franklin Institute, named after the pioneering woman scientist who paved the way for the discovery of the molecular structure of DNA by Crick and Watson.
It will bring together academic and industry researchers to tackle major challenges in health and life sciences and accelerate the discovery of new treatments for chronic diseases affecting millions of people around the world, such as dementia.
The second project on the Harwell research campus is the National Satellite Testing Facility.
This will allow the UK space industry to competitively bid for assembly, integration and testing of space payloads and satellites, positioning the UK to capitalise on the estimated 3,500 -10,000 satellites that are due to be launched by 2025.
The Harwell Campus is a public private partnership between Harwell Oxford Partners, U+I Group PLC, the Science and Technology Facilities Council and the UK Atomic Energy Agency (UKAEA).
As one of the world’s most important science and innovation locations it is seeing rapid growth in the Life Sciences and HealthTec sector with over 1,000 people working in this field alone at Harwell.
The Science and Technology Facilities Council is a UK government body that carries out civil research in science and engineering, and funds UK research in areas including particle physics, nuclear physics, space science and astronomy.
Mark Castle, Mace’s Deputy Chief Operating Officer said: “Both the Rosalind Franklin Institute and the National Satellite Testing Facility have enormous potential to revolutionise their respective scientific fields and to deliver huge commercial and research value for the UK.”